Skip to main content
. 2015 Aug 1;16(4):396–400. doi: 10.1089/sur.2014.211

Table 2.

Comorbidities in Patients with and without MRSA IAI

  Non-MRSA IAI n=195 MRSA IAI n=45 p*
Diabetes mellitus 39 (20%) 15 (33%) 0.05
Coronary artery disease 32 (16%) 6 (13%) 0.61
Peripheral vascular disease 7 (4%) 5 (11%) 0.04
Chronic kidney disease 14 (7%) 6 (13%) 0.18
Chronic pulmonary disease 31 (16%) 10 (22%) 0.31
History of malignant disease 20 (10%) 2 (4%) 0.39
Liver disease 13 (7%) 4 (9%) 0.53
Pre-admission corticosteroid use 46 (24%) 8 (18%) 0.40
Inflammatory bowel disease 16 (8%) 8 (18%) 0.05
*

Significance p<0.05

MRSA=methicillin-resistant Staphylococcus aureus (MRSA); IAI=intra-abdominal infection.